Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Aug 8, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.
|
0
|
$190.84 | -$2,882,133.97 |
—
| 136 |
Aug 6
|
Scheduled
| ||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Rani Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 29
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 4
| |||||||
Rani Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 16
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Rani Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
| 136 |
—
|
—
|
∞
| 136 |
Feb 23
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$145.55 | -$3,350,362.50 |
—
|
0
|
Nov 21
|
Scheduled
| ||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 22
| |||||||
Rani Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Rani Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Rani Therapeutics Holdings, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 15
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 26
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Pfizer Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 26
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$104.91 | -$1,543,608.38 |
—
|
0
|
Mar 13
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$80.05 | -$1,998,200.00 |
—
|
0
|
Nov 2
|
Scheduled
| ||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Pfizer Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 27
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
Pfizer Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 28
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 25
| |||||||
Seres Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Pfizer Inc
|
0
|
—
|
—
|
—
|
0
|
Apr 23
| |||||||
Alnylam Pharmaceuticals, Inc.
| -8.16K |
$130.02 | -$1,061,613.30 | -100.00% |
0
|
Apr 21
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| -5.00K |
$120.00 | -$600,000.00 | -37.98% | 8.16K |
Mar 19
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.